دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer.
Bosl, George J. MD, FASCO, MACP 1,2,3,
doi : 10.1200/JCO.23.00634
Volume 41(22) pgs. 3769-3877 August 1, 2023
JCO Flashback: Long-Term Outcomes of Radical Cystectomy in Patients With Invasive Bladder Cancer (2001).
doi : 10.1200/JCO.23.01126
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients.
Stein, John P.; Lieskovsky, Gary; Cote, Richard; Groshen, Susan; Feng, An-Chen; Boyd, Stuart; Skinner, Eila; Bochner, Bernard; Thangathurai, Duriayai; Mikhail, Maged; Raghavan, Derek; Skinner, DonaldG.
doi : 10.1200/JCO.22.02762
Tradeoffs of Proceeding to Resection Rather Than Mediastinoscopy After Negative Endosonography.
Farjah, Farhood MD, FACS 1,
doi : 10.1200/JCO.23.00782
Mediastinal Staging in Non-Small-Cell Lung Cancer: Saying Goodbye to Mediastinoscopy.
Dunne, Elizabeth G. MD 1; Fick, Cameron N. MD 1; Jones, David R. MD 1,2,,
doi : 10.1200/JCO.23.00867
Debunking Sex and Disentangling Gender From Oncology.
Alpert, Ash B. MD, MFA 1,2,3,; Rivers, Lexis MSN, RN, CNL 4; Manzano, Charlie BA 4; Ruddick, Roman 4; Adams, Spencer BS 5; Obedin-Maliver, Juno MD, MPH, MAS 6,7,8,; Harvey, R. Donald PharmD, FCCP, FHOPA 9,10,; Griggs, Jennifer J. MD, MPH 11,12,; Operario, Don PhD 13,14
doi : 10.1200/JCO.22.02037
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.
Harbeck, Nadia MD, PhD 1,2,,; Nitz, Ulrike A. MD 1,3,; Christgen, Matthias MD, PhD 4; Kummel, Sherko MD, PhD 1,5,6,; Braun, Michael MD 7,; Schumacher, Claudia MD, PhD 8; Potenberg, Jochem MD 9; Tio, Joke MD 10,; Aktas, Bahriye MD, PhD 11,12,; Forstbauer, Helmut MD 13,; Grischke, Eva-Maria MD, PhD 14; Scheffen, Iris MD 1,3,; Malter, Wolfram MD 15,; von Schumann, Raquel MD 3,; Just, Marianne MD 16; zu Eulenburg, Christine PhD 1,17,; Biehl, Claudia MD 18; Kolberg-Liedtke, Cornelia MD, PhD 6,11,; Deurloo, Regula PhD 19,; de Haas, Sanne PhD 19,; Jozwiak, Katarzyna PhD 20; Hauptmann, Michael PhD 20; Kates, Ronald PhD 1,; Graeser, Monika MD 1,3,21; Wuerstlein, Rachel MD 1,2,; Kreipe, Hans H. MD, PhD 4,; Gluz, Oleg MD 1,3,22,; on behalf of the WSG-ADAPT investigators
doi : 10.1200/JCO.22.01816
Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial.
Bousema, Jelle E. MD 1; Dijkgraaf, Marcel G.W. PhD 2; van der Heijden, Erik H.F.M. MD, PhD 3,; Verhagen, Ad F.T.M. MD, PhD 4; Annema, Jouke T. MD, PhD 5,; van den Broek, Frank J.C. MD, PhD 6,; on behalf of the MEDIASTrial study group; on behalf of the MEDIASTrial study group; Papen-Botterhuis, Nicole E.; Youssef-El Soud, Maggy; van Boven, Wim J.; Daniels, Johannes M.A.; Heineman, David J.; Zandbergen, Harmen R.; Brocken, Pepijn; Horn, Thirza; Steup, Willem H.; Braun, Jerry; Ramai, Rajen S.R.S.; Beck, Naomi; Hoeijmakers, Fieke; Barlo, Nicole P.; van Dorp, Martijn; Schreurs, W. Hermien; Dingemans, Anne-Marie C.; Sprooten, Roy T.M.; Maessen, Jos G.; Claessens, Niels J.M.; Lardenoije, Jan-Willem H.P.; Hiddinga, Birgitta I.; Van De Wauwer, Caroline; van der Wekken, Anthonie J.; Hanselaar, Wessel E.; ThJ Kortekaas, Robert; Bard, Martin P.; Rijna, Herman; Bootsma, Gerben P.; Vissers, Yvonne L.J.; Veen, Eelco J.; van der Leest, Cor H.; Citgez, Emanuel; van Duyn, Eino B.; Marres, Geertruid M.H.; van Thiel, Eric R.; van Schil, Paul E.; van Meerbeeck, Jan P.; Wener, Reinier; Smakman, Niels; van der Meer, Femke; Saboerali, Mohammed D.; Bosch, Anne Marie; de Jong, Wouter K.; van Rossem, Charles C.; Lie, W. Johan; Kouwenhoven, Ewout A.; Staal-van den Brekel, A. Jeske; Hanneman, Nike M.; Heller-Baan, Roxane; Noyez, Valentin J.J.M.
doi : 10.1200/JCO.22.01728
Sex and Tumor-Site Differences in the Association of Alcohol Intake With the Risk of Early-Onset Colorectal Cancer.
Jin, Eun Hyo MD, PhD 1,2; Han, Kyungdo PhD 3; Shin, Cheol Min MD, PhD 1,4,; Lee, Dong Ho MD, PhD 1,4; Kang, Seung Joo MD, PhD 1,2; Lim, Joo Hyun MD, PhD 1,2; Choi, Yoon Jin MD, PhD 5
doi : 10.1200/JCO.22.01895
Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
Bates, James E. MD 1,,; Shrestha, Suman PhD 2; Liu, Qi MSc 3; Smith, Susan A. MPH 2; Mulrooney, Daniel A. MD, MS 4,5,; Leisenring, Wendy ScD 6; Gibson, Todd PhD 7; Robison, Leslie L. PhD 4; Chow, Eric J. MD, MPH 6,; Oeffinger, Kevin C. MD 8; Armstrong, Gregory T. MD, MSCE 4,; Constine, Louis S. MD 9,10,; Hoppe, Bradford S. MD, MPH 11,; Lee, Choonsik PhD 7; Yasui, Yutaka PhD 4; Howell, Rebecca M. PhD 2,
doi : 10.1200/JCO.22.02320
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.
Antonarakis, Emmanuel S. MD 1,2,,; Park, Se Hoon MD, PhD 3,; Goh, Jeffrey C. MBBS, FRACP 4,; Shin, Sang Joon MD, PhD 5; Lee, Jae Lyun MD, PhD 6,; Mehra, Niven MD, PhD 7,; McDermott, Ray MD, PhD 8,; Sala-Gonzalez, Nuria MD 9,; Fong, Peter C. MBBS, FRACP 10,; Greil, Richard MD 11,; Retz, Margitta MD, PhD 12; Sade, Juan Pablo MD 13; Yanez, Patricio MD 14,; Huang, Yi-Hsiu MD, PhD 15,; Begbie, Stephen D. MD 16,; Gafanov, Rustem Airatovich MD 17,; De Santis, Maria MD 18,19,; Rosenbaum, Eli MD 20,; Kolinsky, Michael P. MD, FRCPC 21,; Rey, Felipe MD 22,; Chiu, Kun-Yuan 23; Roubaud, Guilhem MD 24,; Kramer, Gero MD 25,; Sumitomo, Makoto MD, PhD 26; Massari, Francesco MD 27; Suzuki, Hiroyoshi MD, PhD 28,; Qiu, Ping PhD 29,; Zhang, Jinchun PhD 29,; Kim, Jeri MD, MBA 29,; Poehlein, Christian H. MD 29,; Yu, Evan Y. MD 30,
doi : 10.1200/JCO.23.00233
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
Bauman, Julie E. MD, MPH 1,2,; Saba, Nabil F. MD 3,; Roe, Denise DrPh 4,5; Bauman, Jessica R. MD 6; Kaczmar, John MD 7,; Bhatia, Aarti MD 8,; Muzaffar, Jameel MD 9; Julian, Ricklie MD 2,; Wang, Steven MD 10; Bearelly, Shethal MD 10,; Baker, Audrey MD 10; Steuer, Conor MD 3,; Giri, Anshu MD 6; Burtness, Barbara MD 8,; Centuori, Sara PhD 2; Caulin, Carlos PhD 10; Klein, Robert MD 11; Saboda, Kathylynn MS 5,; Obara, Stefanie BS 2,; Chung, Christine H. MD 9,
doi : 10.1200/JCO.22.01994
Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer.
Kermorgant, Stephanie PhD 1,
doi : 10.1200/JCO.23.00460
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.
Wolff, Antonio C. MD 1,,; Somerfield, Mark R. PhD 2; Dowsett, Mitchell PhD 3,; Hammond, M. Elizabeth H. MD 4,; Hayes, Daniel F. MD 5,; McShane, Lisa M. PhD 6; Saphner, Thomas J. MD 7; Spears, Patricia A. BS 8,; Allison, Kimberly H. MD 9,
doi : 10.1200/JCO.22.02864
Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Hindie, Elif MD, PhD
doi : 10.1200/JCO.23.00686
Reply to E. Hindie.
McManus, Hannah D. MD; Armstrong, Andrew J. MD, ScM, FACP
doi : 10.1200/JCO.23.00794
Consent in Pharmacogenetic Testing.
Ando, Yuichi MD, PhD; Terada, Tomohiro PhD
doi : 10.1200/JCO.23.00664
Erratum: Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.
doi : 10.1200/JCO.23.00658
Erratum: Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer.
doi : 10.1200/JCO.23.00870
